GLP-1 receptor agonists (GLP-1RA) such as liraglutide has emerged as a new treatment for PCOS in recent years as GLP-1 has many unique advantages for the treatment of metabolic diseases such as inhibition of gastric emptying and food intake and augmentation of insulin secretion [158]. Here, GLP1R is linked to metabolic disease.